Search results
EMA Panel Endorses Novavax's (NVAX) COVID Jab for Full Approval
Zacks via Yahoo Finance· 11 months agoNovavax's (NVAX) protein-based COVID-19 vaccine gets recommendation for full marketing authorization...
Novavax's (NVAX) COVID-19 Jab Gets Approval in Switzerland
Zacks via Yahoo Finance· 2 years agoNovavax (NVAX) receives expanded temporary authorization for Nuvaxovid, its COVID-19 vaccine, in...
Novavax Stock Is Too Sickly To Buy
InvestorPlace via Yahoo Finance· 2 years agoNovavax’s Covid-19 vaccine still isn’t approved for use in the U.S. With the pandemic in full retreat and the majority of people now fully vaccinated,...
Novavax CEO eyes next batch of COVID-19 vaccines after CDC approval
Yahoo Finance· 2 years agoNovavax passed the finish line to gain authorization for its COVID-19 vaccine, and its first...
Novavax (NVAX) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 12 months agoWe expect investors to focus on the pipeline when Novavax, Inc. NVAX reports first-quarter 2023...
Novavax Covid Vaccine Could Soon Win EUA Approval — And So What?
TipRanks via Yahoo Finance· 2 years agoAt long last, Novavax (NVAX) may be close to getting its EUA. As the company announced late Tuesday,...
The U.S.’s woefully low COVID vaccination rate makes it Novavax’s most appealing market yet
Fortune via Yahoo Finance· 2 years agoOn Wednesday, the U.S. Centers for Disease Control (CDC) approved the COVID-19 vaccine from...
Novavax (NVAX) Q4 Earnings & Revenues Miss Estimates, Stock Down
Zacks via Yahoo Finance· 1 year agoNovavax (NVAX) reports worse-than-expected financial performance in the fourth quarter of 2022, with...
Novavax, Inc. (NASDAQ:NVAX) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 months agoNovavax, Inc. (NASDAQ:NVAX) Q4 2023 Earnings Call Transcript February 28, 2024 Novavax, Inc. misses...
Novavax Tanks On New Troubles For Its Newly Authorized Covid Vaccine
Investor's Business Daily· 2 years agoNovavax won Food and Drug Administration approval for its Covid vaccine — ending a six-month wait —...
